Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial
- Resource Type
- Article
- Authors
- Misawa, S; Kuwabara, S; Sato, Y; Yamaguchi, N; Nagashima, K; Katayama, K; Sekiguchi, Y; Iwai, Y; Amino, H; Suichi, T; Yokota, T; Nishida, Y; Kanouchi, T; Kohara, N; Kawamoto, M; Ishii, J; Kuwahara, M; Suzuki, H; Hirata, K; Kokubun, N; Masuda, R; Kaneko, J; Yabe, I; Sasaki, H; Kaida, K; Takazaki, H; Suzuki, N; Suzuki, S; Nodera, H; Matsui, N; Tsuji, S; Koike, H; Yamasaki, R; Kusunoki, S; Nagashima, T; Shimizu, T; Hirotani, M; Kadoya, M; Nakahara, J; Shimizu, J; Tanaka, M; Sobue, G; Katsuno, M; Yamaguchi, H; Ogata, H; Misawa, Sonoko; Kuwabara, Satoshi; Sato, Yasunori; Yamaguchi, Nobuko; Nagashima, Kengo; Katayama, Kanako; Sekiguchi, Yukari; Iwai, Yuta; Amino, Hiroshi; Suichi, Tomoki; Yokota, Takanori; Nishida, Yoichiro; Kanouchi, Tadashi; Kohara, Nobuo; Kawamoto, Michi; Ishii, Junko; Kuwahara, Motoi; Suzuki, Hidekazu; Hirata, Koichi; Kokubun, Norito; Masuda, Ray; Kaneko, Juntaro; Yabe, Ichiro; Sasaki, Hidenao; Kaida, Ken-ichi; Takazaki, Hiroshi; Suzuki, Norihiro; Suzuki, Shigeaki; Nodera, Hiroyuki; Matsui, Naoko; Tsuji, Shoji; Koike, Haruki; Yamasaki, Ryo; Kusunoki, Susumu
- Source
- In The Lancet Neurology June 2018 17(6):519-529
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1474-4422